Abstract
Purpose
Internal biliary stenting (IBS) was reported to decrease biliary complications after liver transplantation (LT) but data in literature is scarce. The aim of the present study was to evaluate our experience with end-to-end choledoco-choledocostomy during liver transplantation with special focus on the influence of IBS on patient and biliary outcomes.
Methods
Between 2009 and 2013, 175 patients underwent deceased donor LT with end-to-end choledoco-choledocostomy and were included in the study. Supra-papillary silastic stent was inserted in 67 patients (38%) with small-size (< 5 mm) bile ducts (recipient or donor). Endoscopic retrograde cholangiopancreatography (ERCP) was scheduled for IBS removal, 6 months after LT. Operative outcomes and survival of patients who received internal stenting (IBS group) were compared with those of patients who did not (no-IBS group). Risk factors for biliary anastomotic complications were identified.
Results
Ten patients died (6%) and 104 (59%) experienced postoperative complications. Five-year patient and graft survival rates were 77 and 74%, respectively. Biliary complications were recorded in 61 patients (35%) and were significantly decreased by IBS insertion (p = 0.0003). Anastomotic fistulas occurred in 23 patients (13%) and stenoses in 44 patients (25%). On multivariate analysis, high preoperative MELD scores (p = 0.02) and hepatic artery thrombosis (p < 0.0001) were predictors of fistula; absence of IBS was associated with both fistula (p = 0.014) and stricture (p = 0.003) formation.
Conclusions
IBS insertion during LT decreases anastomotic complication.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader https://ift.tt/2pAdu9k




Mark your calendars for the McGovern Medical School Department of Otorhinolaryngology-Head and Neck Surgery's two-day CME meeting in the Texas...
When J. Caleb Simmons, MD, started medical school, he thought he might be a pediatrician. Today as an otolaryngologist, nearly...
Otolaryngologist Michael Byrd, MD, has been recognized as 2017 Physician of the Year at Memorial Hermann Southeast Hospital, a 274-bed... 
iHear Medical (https://ift.tt/1pm5Mpw) is partnering with Atlazo to develop an advanced digital hardware platform, System on Chip (SoC), which will power a new operating system designed to shift devices from relying on visual displays to voice commands and the auditory domain for hearing aids and hearables. With the Hearing of Things (HoT) operating system, users can selectively listen to and send communications to their social media accounts and text messages with hearing devices instead of their cell phone or computer, eliminating the need to be tethered to traditional computing devices for sending and receiving information. The HoT standard will offer bi-directional wireless connectivity to everyday devices, from mobile phones to home appliances. Hearing devices powered by the HoT operating system will streamline the user experience for mobile phones, including phone calling and control of home appliances with a voice user interface. These devices will also offer real-time health tracking and relay personal and health information into the ear privately and discreetly. 
